#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell lymphoma refractory Congenital leptin deficiency Primary amyloidosis Lymphatic malformation KBG syndrome Hyperphagia Glomerulonephritis acute Neuromyelitis optica spectrum disorder Neutropenia Osteosarcoma Essential thrombocythaemia Eosinophilic oesophagitis Non-Hodgkin's lymphoma unspecified histology indolent Inclusion body myositis Dedifferentiated liposarcoma More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Diagnostics Krabbe’s disease – Trials in Disease Inclusion body myositis – Basic Information Glomerulonephritis rapidly progressive – Treatment Pituitary-dependent Cushing’s syndrome – Life with Disease Stevens-Johnson syndrome – Diagnostics Idiopathic inflammatory myopathy Soft tissue sarcoma – Basic Information Skin angiosarcoma – Trials in Disease Arterial tortuosity syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bromhexine Hydrochloride Gad20-209-Fsp-A1 Micafungin Interferon Beta-1A Sodium Oxybate H2-Receptor Antagonists Prilocaine TIFCEMALIMAB Danicamtiv Ulonivirine Ttx-030 AZD0516 Macrogol 4000 Inebilizumab Levothyroxine XYLOMETAZOLINE HYDROCHLORIDE Camonsertib ADS-019 Dersimelagon Phosphate Mbf-015 More therapies…

    Learn about Your Condition

    Tachypnoea Ischaemic skin ulcer Stargardt's disease Transient ischaemic attack Anogenital dysplasia Muscle strain Mantle cell lymphoma stage IV Hypotension Biopsy heart Gestational diabetes Frontotemporal dementia Cardiac failure acute Andersen-Tawil syndrome Liposarcoma Breast cancer female More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Digitoxin with Chemotherapy for Patients with Inoperable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Digitoxin
    Sweden

  • Study on Tricortin 1000, Diclofenac Sodium, and Paracetamol for Patients with Chronic Low Back Pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cyanocobalamin
    • Diclofenac Sodium
    • Phospholipid From Cerebral Cortex.
    Italy

  • Study on Preventing Blood Clots in Pancreatic Cancer Patients Using Tinzaparin Sodium and Enoxaparin Sodium During Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    • Pancreatic carcinoma
    Investigated Drugs:
    • Tinzaparin Sodium
    • Enoxaparin Sodium
    Finland

  • Study Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine Hydrochloride
    France

  • Study Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma recurrent
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Daratumumab
    France

  • Study on the Safety of TOP-N53 for Treating Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    2 1 1
    Investigated Drugs:
    • 2-[1-(3-{6-[(1E)-(Hydroxyimino)Methyl]-5-Methyl-4-Oxo-7-Propyl-3H,4H-Pyrrolo[2,1-F][1,2,4]Triazin-2-Yl}-4-Propoxybenzenesulfonyl)Piperidin-4-Yl]Ethyl Nitrate
    • Sildenafil Citrate
    France
Previous Page
1 … 305 306 307 308 309 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!